Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease

References

Page 1

	Year	Citations
Design and validation of a histological scoring system for nonalcoholic fatty liver disease† David E. Kleiner, Elizabeth M. Brunt, Mark L. Van Natta, Hepatology Nafld Activity ScoreDiagnosisPathologyGastroenterologyFatty Liver Disease	2005	10.5K
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions Elizabeth M. Brunt, Christine G. Janney, Adrian M. Di Bisceglie, The American Journal of Gastroenterology	1999	3.8K
Nonalcoholic Fatty Liver Disease Giulio Marchesini, Mara Brizi, Giampaolo Bianchi, Diabetes	2001	2.6K
Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡ Mattias Ekstedt, Lennart Franzén, Ulrik Mathiesen, Hepatology	2006	2.3K
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells Volker Henn, Joseph R. Slupsky, Michael Gräfe, Nature InflammationThrombosisThrombopoiesisEndothelial CellsBlood Platelet	1998	2.1K
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease† Nicola Villanova, Simona Moscatiello, Stefano Ramilli, Hepatology	2005	619
Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 John Willy Haukeland, Jan Kristian Damås, Zbigniew Konopski, Journal of Hepatology ImmunologyPathologyFatty Liver DiseaseInflammationMetabolic Syndrome	2006	596
Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis Anna Więckowska, Bettina G. Papouchado, ZhengZheng Li, The American Journal of Gastroenterology	2008	594
High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and Women Anna Margrethe Thøgersen, Jan‐Håkan Jansson, Kurt Boman, Circulation	1998	592
Nonalcoholic Fatty Liver Disease and Risk of Future Cardiovascular Events Among Type 2 Diabetic Patients Giovanni Targher, Lorenzo Bertolini, Felice Poli, Diabetes Cardiometabolic RiskFuture Cardiovascular DiseaseDiabetic PatientsFatty Liver DiseaseObesity	2005	574

Page 1